Pharmaceutical firms fared worse in 1Q

Korea’s major pharmaceutical firms saw their earnings decline 43 percent for the first quarter of this year due to hurried disposal of drug inventories ahead of government-mandated cuts in drug prices in April 1.

According to the data compiled by Yakup.com, a pharmaceutical information provider, the combined operating profit of 14 listed companies reached 874.6 billion won in the first quart...